Angiogenesis
Angiogenesis inhibitors are compounds that interfere with the formation of new blood vessels, a process critical in cancer growth and metastasis. By inhibiting angiogenesis, these compounds can restrict the blood supply to tumors, slowing or halting their growth. Angiogenesis inhibitors are essential in cancer research and therapeutic development, providing insights into the mechanisms of tumor progression and offering potential treatments for cancer and other angiogenesis-related diseases. At CymitQuimica, we offer a wide range of high-quality angiogenesis inhibitors to support your research in oncology and vascular biology.
Read more
Subcategories of "Angiogenesis"
Show 6 more subcategories
Products of "Angiogenesis"
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | HIF-2α-IN-1 REF: TM-T15482CAS: 1799948-06-3 | 97.99% | To inquire | Wed 05 Feb 25 |
| AFP464 free base REF: TM-T10258CAS: 468719-52-0 | 98% | 1,468.00 €~4,019.00 € | Wed 05 Mar 25 |
| (Rac)-PT2399 REF: TM-T12675CAS: 1672662-07-5 | - - - | 113.00 €~2,050.00 € | Wed 05 Mar 25 |
| CHMFL-ABL-121 REF: TM-T10800CAS: 2270879-07-5 | 99.86% | - - - | Discontinued product |
| CHMFL-FLT3-122 REF: TM-T27011CAS: 1839150-56-9 | 99.56% | - - - | Discontinued product |
| Bosutinib D8 REF: TM-T10583 | 98% | - - - | Discontinued product |
| CHMFL-ABL-039 REF: TM-T10799CAS: 2304344-56-5 | 98.63% | - - - | Discontinued product |
HIF-2α-IN-1
CAS:1799948-06-3
HIF-2α-IN-1 is a potent HIF-2α inhibitor with IC50 values less than 500 nM.
Formula:
C16H8F5NO4S
Purity:
97.99%
Color and Shape:
Solid
Molecular weight:
405.3
Ref: TM-T15482
| 1mg | 97.00 € | ||
| 5mg | 232.00 € | ||
| 10mg | 378.00 € | ||
| 1mL*10mM (DMSO) | 256.00 € |
Estimated delivery in United States, on Wednesday 5 Feb 2025
AFP464 free base
CAS:468719-52-0
AFP464 (NSC710464) free base is an active HIF-1α inhibitor (IC50: 0.25 μM) and a potent …
Formula:
C22H23F3N4O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
448.44
Ref: TM-T10258
| 25mg | 2,245.00 € | ||
| 50mg | 2,972.00 € | ||
| 100mg | 4,019.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
(Rac)-PT2399
CAS:1672662-07-5
(Rac)-PT2399 is a potent and specific inhibitor of hypoxia-inducible factor 2a (HIF-2α)(IC50 of 0.01 μM).
Formula:
C17H10F5NO4S
Color and Shape:
Solid
Molecular weight:
419.32
Ref: TM-T12675
| 5mg | 325.00 € | ||
| 25mg | 916.00 € | ||
| 50mg | 1,273.00 € | ||
| 100mg | 2,050.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
CHMFL-ABL-121
CAS:2270879-07-5
CHMFL-ABL-121 is a highly potent inhibitor of type II ABL kinase (IC50s: 2 nM and …
Formula:
C30H31F3N6OS
Purity:
99.86%
Color and Shape:
Solid
Molecular weight:
580.67
Ref: TM-T10800
| 1mg | Discontinued | Request information | |
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information | |
| 1ml*10 (DMSO) | Discontinued | Request information |
CHMFL-FLT3-122
CAS:1839150-56-9
CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive …
Formula:
C26H29N7O2
Purity:
99.56%
Color and Shape:
Solid
Molecular weight:
471.55
Ref: TM-T27011
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
Bosutinib D8
Bosutinib D8 is a deuterium-labeled Bosutinib. Bosutinib (SKI-606) is a dual Src/Abl inhibitor (IC50s: 1.2 …
Formula:
C26H21D8Cl2N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
538.5
Ref: TM-T10583
| 100mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
CHMFL-ABL-039
CAS:2304344-56-5
CHMFL-ABL-039 is a type II native ABL kinase and drug-resistant V299L mutant BCR-ABL inhibitor (IC50s: …
Formula:
C31H33F3N6O3
Purity:
98.63%
Color and Shape:
Solid
Molecular weight:
594.63
Ref: TM-T10799
| 1mg | Discontinued | Request information | |
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 1ml*10 (DMSO) | Discontinued | Request information |
